Episode
Unpacking the ActBlue Hearing: Senator Blackburn on Term Limits and Congressman Clyde on FISA Reform
- Podcast
- John Solomon Reports
- Published
- Jun 10, 2026
- Duration seconds
- 1977
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/john-solomon-reports-1030390/episodes/unpacking-the-actblue-hearing-senator-blackburn-on-term-limits-and-congressman-clyde-on-fisa-reform/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/john-solomon-reports-1030390/unpacking-the-actblue-hearing-senator-blackburn-on-term-limits-and-congressman-clyde-on-fisa-reform.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of John Solomon Reports , we dive into the latest developments surrounding the ActBlue investigation, which has gained traction in Congress, the Treasury Department, and the FBI after years of reporting. Host John Solomon sets the stage for an impactful discussion, starting with Senator Marsha Blackburn, who shares her strategies for advancing the Save America Act and discusses the pressing issue of term limits in Congress. Next, Congressman Andrew Clyde of Georgia joins to provide insights on the urgent FISA reform as the law approaches its expiration. Clyde addresses the political tension surrounding the potential renewal and the implications of President Trump's temporary pick to run the DNI. In the third segment, Dr. Peter McCullough, a trusted voice on health issues from The Wellness Company, returns to discuss the recent panic over Ebola and reassures listeners about its potential impact. He also touches on emerging studies regarding the use of Ivermectin and Mebendazole in cancer treatment, sparking interest in their possible therapeutic benefits. Additionally, John highlights significant news from the military front, including President Trump's ordered strikes on Iran in response to recent provocations, as well as a dramatic hearing where the CEO of ActBlue invoked her Fifth Amendment rights during questioning about foreign funding and possible deception before Congress. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info .